There are 2949 resources available
Improving outcomes with immunotherapy in urothelial cancer: Perspectives on the latest data
Presenter: Enrique Grande
Session: F. Hoffmann-La Roche - Reshaping treatment paradigms for GU cancer patients: Perspectives on PI3K/AKT inhibitors in mCRPC and immunotherapy in urothelial cancer
Resources:
Webcast
The changing landscape of metastatic prostate cancer: Challenges and evolving opportunities
Presenter: Karim Fizazi
Session: F. Hoffmann-La Roche - Reshaping treatment paradigms for GU cancer patients: Perspectives on PI3K/AKT inhibitors in mCRPC and immunotherapy in urothelial cancer
Resources:
Webcast
Targeting AKT: Next breaAKThrough therapies for prostate cancer care?
Presenter: Johann de Bono
Session: F. Hoffmann-La Roche - Reshaping treatment paradigms for GU cancer patients: Perspectives on PI3K/AKT inhibitors in mCRPC and immunotherapy in urothelial cancer
Resources:
Webcast
Welcome and introduction
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
ADCs as a technologically advanced treatment approach in solid tumours
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Current clinical experience with innovative ADCs in breast cancer
Presenter: Javier Cortés
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Latest findings from clinical trials in lung cancer with technologically advanced ADCs
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Recent clinical findings with novel ADCs in colorectal and gastric cancer
Presenter: Kanwal Raghav
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Summary and close
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
From breast cancer to other tumors: Lessons learned from targeting the HER pathway
Presenter: Javier Cortés
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast